Panagora Asset Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,038
| Closed | -$68.1K | – | 1151 |
|
|
2025
Q1 | $68.1K | Sell |
12,038
-4,363
| -27% | -$55.9K | ﹤0.01% | 1089 |
|
|
2024
Q4 | $346K | Buy |
16,401
+6,924
| +73% | +$159K | ﹤0.01% | 920 |
|
|
2024
Q3 | $255K | Buy |
+9,477
| New | +$279K | ﹤0.01% | 1087 |
|
|
2022
Q3 | – | Sell |
-5,932
| Closed | -$214K | – | 1473 |
|
|
2022
Q2 | $214K | Sell |
5,932
-5,629
| -49% | -$254K | ﹤0.01% | 1392 |
|
|
2022
Q1 | $718K | Hold |
11,561
| – | – | ﹤0.01% | 1081 |
|
|
2021
Q4 | $815K | Buy |
11,561
+3,409
| +42% | +$242K | ﹤0.01% | 1012 |
|
|
2021
Q3 | $569K | Buy |
8,152
+2,922
| +56% | +$233K | ﹤0.01% | 1255 |
|
|
2021
Q2 | $436K | Buy |
5,230
+4,882
| +1,403% | +$345K | ﹤0.01% | 1377 |
|
|
2021
Q1 | $19K | Buy |
348
+202
| +138% | +$9.83K | ﹤0.01% | 2314 |
|
|
2020
Q4 | $6K | Sell |
146
-1,209
| -89% | -$45.1K | ﹤0.01% | 2412 |
|
|
2020
Q3 | $41K | Buy |
1,355
+29
| +2% | +$975 | ﹤0.01% | 2064 |
|
|
2020
Q2 | $41K | Buy |
+1,326
| New | +$35.7K | ﹤0.01% | 2022 |
|
|
2020
Q1 | – | Sell |
-106
| Closed | -$3K | – | 2549 |
|
|
2019
Q4 | $3K | Hold |
106
| – | – | ﹤0.01% | 2322 |
|
|
2019
Q3 | $3K | Sell |
106
-3,742
| -97% | -$93K | ﹤0.01% | 2348 |
|
|
2019
Q2 | $77K | Sell |
3,848
-1,560
| -29% | -$45.7K | ﹤0.01% | 2019 |
|
|
2019
Q1 | $233K | Sell |
5,408
-11
| -0.2% | -$399 | ﹤0.01% | 1656 |
|
|
2018
Q4 | $172K | Buy |
5,419
+5,408
| +49,164% | +$213K | ﹤0.01% | 1669 |
|
|
2018
Q3 | $1K | Sell |
11
-1,540
| -99% | -$86.4K | ﹤0.01% | 2387 |
|
|
2018
Q2 | $83K | Sell |
1,551
-256
| -14% | -$13.1K | ﹤0.01% | 1904 |
|
|
2018
Q1 | $90K | Hold |
1,807
| – | – | ﹤0.01% | 1881 |
|
|
2017
Q4 | $60K | Buy |
1,807
+780
| +76% | +$26.3K | ﹤0.01% | 2020 |
|
|
2017
Q3 | $38K | Sell |
1,027
-219
| -18% | -$6.48K | ﹤0.01% | 2097 |
|
|
2017
Q2 | $32K | Sell |
1,246
-715
| -36% | -$17.7K | ﹤0.01% | 2154 |
|
|
2017
Q1 | $51K | Buy |
1,961
+537
| +38% | +$15.5K | ﹤0.01% | 2015 |
|
|
2016
Q4 | $43K | Sell |
1,424
-3,028
| -68% | -$77K | ﹤0.01% | 2119 |
|
|
2016
Q3 | $121K | Buy |
4,452
+1,617
| +57% | +$44.9K | ﹤0.01% | 1913 |
|
|
2016
Q2 | $81K | Sell |
2,835
-6,378
| -69% | -$203K | ﹤0.01% | 1961 |
|
|
2016
Q1 | $278K | Sell |
9,213
-3,999
| -30% | -$113K | ﹤0.01% | 1543 |
|
|
2015
Q4 | $458K | Buy |
13,212
+2,900
| +28% | +$99.2K | ﹤0.01% | 1348 |
|
|
2015
Q3 | $390K | Buy |
10,312
+2,972
| +40% | +$138K | ﹤0.01% | 1396 |
|
|
2015
Q2 | $418K | Buy |
7,340
+7,147
| +3,703% | +$407K | ﹤0.01% | 1403 |
|
|
2015
Q1 | $11K | Sell |
193
-1,885
| -91% | -$101K | ﹤0.01% | 2279 |
|
|
2014
Q4 | $118K | Sell |
2,078
-8,007
| -79% | -$382K | ﹤0.01% | 1813 |
|
|
2014
Q3 | $412K | Buy |
10,085
+3,420
| +51% | +$157K | ﹤0.01% | 1375 |
|
|
2014
Q2 | $303K | Sell |
6,665
-4,452
| -40% | -$187K | ﹤0.01% | 1566 |
|
|
2014
Q1 | $527K | Buy |
11,117
+2,287
| +26% | +$104K | ﹤0.01% | 1396 |
|
|
2013
Q4 | $415K | Buy |
8,830
+1,640
| +23% | +$71.6K | ﹤0.01% | 1460 |
|
|
2013
Q3 | $287K | Buy |
7,190
+4,256
| +145% | +$167K | ﹤0.01% | 1523 |
|
|
2013
Q2 | $105K | Buy |
+2,934
| New | +$112K | ﹤0.01% | 1846 |
|
Other funds holding HBIO
AE
HP
GIM
MIM
